Cyclarity Therapeutics, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2019-11-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.cyclaritytx.com
Placebo-controlled Study of Single and Multiple Ascending Doses of UDP-003 in Healthy Human Participants and Patients
Early Phase 1
Recruiting
- Conditions
- Atherosclerotic Cardiovascular DiseaseAcute Coronary Syndromes
- Interventions
- Other: Placebo
- First Posted Date
- 2025-02-06
- Last Posted Date
- 2025-05-02
- Lead Sponsor
- Cyclarity Therapeutics, Inc.
- Target Recruit Count
- 84
- Registration Number
- NCT06813339
- Locations
- 🇦🇺
CMAX Clinical Research, Adelaide, South Australia, Australia